NCT03937635 2026-03-02Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaEastern Cooperative Oncology GroupPhase 3 Recruiting288 enrolled
NCT05288062 2025-08-20Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple MyelomaMayo ClinicPhase 2 Terminated17 enrolled 9 charts